Multiple Sclerosis (MS) is a neuroinflammatory disease that affects myelin. While researchers haven’t been able to identify the cause of MS with certainty, there has been a tremendous amount of progress in research; especially in the development of treatments to prevent exacerbations.
High-quality samples are paramount in developing new treatments for Multiple Sclerosis. HemaCare sources, isolates, and ships human blood components and cells under rigorously controlled protocols to provide the optimum starting material for your research.
Patients diagnosed with Multiple Sclerosis are recruited as volunteer donors for research products. They review and sign an independent biomedical review board (IRB) approved procedure-specific consent form prior to the collection.
Either prepare cells for long-term storage in Liquid Nitrogen vapor phase or thaw for use. Storage in liquid phase nitrogen is NOT recommended. Short-term storage of cells (less than 2 weeks) at -80°C is acceptable but should be minimized to ensure maximum stability. Once thawed, samples must be used immediately.
Testing: Donors are tested for HBV, HCV, and HIV, unless requested otherwise.
PBMC Flow Data
Please note that the frequency of cell type via principal markers is highly variable and can be significantly influenced by the type of disease, medication prescribed to the donor, and how the donor reacts to the medication. These graphs and their subsequent cell frequencies are representative sample and are not indicative of received samples.